RecruitingOsteoarthritis · Overweight and Obesity
Study for People With Excess Body Weight and Knee Osteoarthritis
Montreal, Quebec
Irritable bowel syndrome, usually shortened to IBS, is a long term condition in which abdominal pain happens together with a change in bowel habit, and routine tests show no damage or disease in the bowel. The gut and the nervous system are not communicating normally, which makes the bowel more sensitive and its movements less predictable. Day to day that can mean cramping, bloating, and bowel movements that are hard to plan around.
IBS is not a diagnosis of last resort. Doctors in Canada make it positively, from a recognised pattern of symptoms, alongside a small set of tests to check for other conditions. It is grouped by the main bowel pattern: IBS with constipation, IBS with diarrhoea, or a mixed pattern that swings between the two. Which group you fall into can change over the years.
IBS is also not a form of cancer or inflammatory bowel disease, and it does not damage the bowel. Some symptoms do overlap with those conditions, which is why doctors look specifically for alarm features such as bleeding or weight loss. If those turn up, they are assessed on their own merits rather than put down to IBS.
Symptoms vary a great deal between people and over time. Many people have settled stretches followed by weeks when the pain and urgency return, sometimes without an obvious reason.

Some risk factors cannot be changed:
Others can often be worked on, usually with support from a health care team:
IBS is a positive diagnosis made with the Rome IV criteria, which describe recurrent abdominal pain that is linked to bowel movements or to changes in the frequency or form of stool over a sustained period. Doctors usually add a small set of tests to rule out other conditions: blood counts, blood tests for celiac disease, C reactive protein as a marker of inflammation, and a stool test for calprotectin or for hidden blood. Colonoscopy is not needed to confirm IBS. It is arranged for people with alarm features, or for those who fall into a colorectal cancer screening group.
Clinical research for Irritable Bowel Syndrome (IBS) is enrolling. See the current studies
Care in Canada is built around reducing pain and urgency and making bowel habits more predictable, and it usually combines more than one approach. Depending on your pattern, what you have already tried and what matters to you, a health care team may discuss:
No two people with IBS end up with the same plan, and finding what helps often takes several attempts. These are decisions for you and your own clinician, and nothing on this page is a recommendation about any of them.
There is still no test that confirms IBS, no way to predict which person will respond to which approach, and a large share of people continue to have symptoms after diet, medicine and psychological therapy. Studies now underway are testing gut microbiome and diet interventions, bile acid and gut barrier targets, new neuromodulators and secretagogues, digital cognitive behavioural therapy and hypnotherapy programs, and biomarkers that could separate the subtypes. Canadian researchers are also examining why reported prevalence differs so widely depending on which criteria are applied.
Clinical studies are how those questions get answered. Taking part is voluntary, you give informed consent before anything begins, and you can stop at any time without affecting the care you get from your own doctor. Joining a study does not mean giving up the care you have now, and no one can say in advance whether a study will help you personally.
This page is written in plain language for people considering clinical research. It is general health information, not medical advice, and it does not replace a conversation with your own doctor or nurse practitioner.
It depends on the definition used. Broad symptom based estimates, such as the 18% figure published by the Canadian Digestive Health Foundation, count anyone reporting the typical pattern. The stricter Rome IV criteria used in a 2023 Canadian survey produced 4.2%. Both describe real people; they simply draw the line in different places.
IBS is not a form of cancer or inflammatory bowel disease and does not damage the bowel. That said, some symptoms overlap, which is why doctors check for alarm features such as bleeding or weight loss. If those appear, they are assessed on their own merits rather than assumed to be IBS.
Often yes. Many studies are designed for people whose symptoms persist despite current treatment, and the study team will review your medicines with you. Each study has its own entry requirements, and the coordinator will tell you clearly whether your current treatment fits before you decide.
RecruitingOsteoarthritis · Overweight and Obesity
Montreal, Quebec
RecruitingOsteoarthritis · Overweight and Obesity
Toronto & Stouffville, Ontario
Recruiting
RecruitingOsteoarthritis · Overweight and Obesity
Ontario · British Columbia
RecruitingHeadaches & Migraines · Pain
Sarnia, Ontario
RecruitingHeadaches & Migraines · Pain
Sarnia, Ontario